Nauru

Reimbursed Care Access

Nauru does not have any known, authorised national medical programs for classic psychedelics (psilocybin, MDMA, DMT, etc.), and there is no public reimbursement framework for psychedelic-assisted therapies. Ketamine is the only substance from this list with a clear, routine medical role globally (as an anaesthetic) and—given Nauru’s basic medical infrastructure—is the only compound likely to be available in clinical/acute-care contexts; however, there is no public evidence of a reimbursed mental‑health or psychedelic‑therapy program in Nauru. Nauru’s health system is small and services are limited, and national medicines regulation and import controls are managed by the Ministry of Health and Medical Services. [https://www.gov.uk/foreign-travel-advice/nauru/health|GOV.UK – Nauru: Health].